Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT07122609 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07122609
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2026-08-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.